Lumexa Imaging Holdings, Inc. (LMRI)

Market Cap	914.69M
Revenue (ttm)	1.03B +10.1%
Net Income	-37.70M
EPS	-0.49
Shares Out	96.08M
PE Ratio	n/a
Forward PE	12.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	934,738
Open	9.16
Previous Close	9.04
Day's Range	9.11 - 9.84
52-Week Range	6.45 - 19.45
Beta	n/a
Analysts	Strong Buy
Price Target	17.29 (+81.62%)
Earnings Date	May 12, 2026

About LMRI

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 11, 2025
• Employees: 4,200
• Stock Exchange: NASDAQ
• Ticker Symbol: LMRI
• Website: https://www.lumexaimaging.com

Financial Performance

In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.

Analyst Summary

According to 8 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $17.29, which is an increase of 81.62% from the latest price.

Price Target

$17.29

(81.62% upside)

Analyst Consensus: Strong Buy